Nov 7 Statement |
UMR Congratulates Dr. Monica Bertagnolli on her Confirmation as the next NIH Director
Why Invest in NIH Research? |
UMR Offers Fact Sheets
Explaining Why Congress Must #keepNIHstrong
Prior treatment with cancer drug likely renders COVID-19 vaccine ineffective, study finds
People who have been treated with rituximab, a widely used cancer drug, or similar drugs respond poorly or not at all to subsequent COVID-19 mRNA vaccines, according to a study by researchers at Stanford Medicine.